Medigift Pharmaceuticals Private Limited
About Medigift Pharmaceuticals Private Limited
Data last updated:
Medigift Pharmaceuticals Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 September 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U51909WB2016PTC217634. Its GSTIN is 19AAKCM6121F1ZH (West Bengal).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Merajuddin (Managing Director) and Ruqaiya Mujtaba.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 18 No. S K Muslim Road Kamarhati Near Sogra Medical Five Point Crossing, Kolkata, West Bengal, India – 700058.
As per the financials filed for FY 2020, the company reported a revenue of ₹4.39 Lakh, a growth of 42% compared to the previous year. For the same year it recorded a net profit of ₹30,033 (net margin 6.8%) and EBITDA of -₹1.66 Lakh (EBITDA margin -37.8%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Medigift Pharmaceuticals Private Limited's registered office is in Kolkata, West Bengal. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address18 No. S K Muslim Road Kamarhati Near Sogra Medical Five Point Crossing, Kolkata, West Bengal, India – 700058
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Medigift Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Medigift Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Medigift Pharmaceuticals Private Limited, buy the company report.
Financials of Medigift Pharmaceuticals Private Limited
FY 2025 filings availableMedigift Pharmaceuticals Private Limited reported revenue of ₹4.39 Lakh (up 42% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue rose 42% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ₹4.39 Lakh | |||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹1.66 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹30,033 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -37.8% | |||
| Net Profit Margin | 6.8% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Medigift Pharmaceuticals Private Limited, buy the company report.
Board of directors of Medigift Pharmaceuticals Private Limited
Medigift Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Merajuddin | Managing Director | 19 Sep 2016 | 10 Years 1 Months | Current |
| Ruqaiya Mujtaba | Director | 29 May 2018 | 8 Years 4 Months | Current |
Auditor
Medigift Pharmaceuticals Private Limited is audited by RAJIB JHA & ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAJIB JHA & ASSOCIATES | FY 2019 | 328920E |
Shareholding
The shareholding of Medigift Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Medigift Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Medigift Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medigift Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Medigift Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AAKCM6121F1ZH | West Bengal | Active | 01 Sep 2018 |
To see the full GST registrations and return filing status of Medigift Pharmaceuticals Private Limited, buy the company report.
Recent activity
Medigift Pharmaceuticals Private Limited has 5 board changes on record since 2016: 2 appointments and 3 cessations. The latest: Supriya Bhattacharjee ceased to be Director on 01 Dec 2020.
Frequently asked questions
Medigift Pharmaceuticals is an active private limited company based in Kolkata, West Bengal, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 September 2016 (10+ years old) and is registered under CIN U51909WB2016PTC217634.
Medigift Pharmaceuticals has 2 current directors:
- Merajuddin - Managing Director
- Ruqaiya Mujtaba - Director
The latest financial statements of Medigift Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Medigift Pharmaceuticals is 19AAKCM6121F1ZH, registered in West Bengal.
The CIN (Corporate Identification Number) of Medigift Pharmaceuticals is U51909WB2016PTC217634. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medigift Pharmaceuticals was incorporated on 19 September 2016, making it 10+ years old. It is registered with the Registrar of Companies, Kolkata.
Supriya Bhattacharjee ceased to be Director on 01 Dec 2020. Umesh Mahato ceased to be Director on 20 Dec 2019. Ruqaiya Mujtaba was appointed as Director on 29 May 2018. Medigift Pharmaceuticals has 5 board changes on record in total.
The registered office of Medigift Pharmaceuticals is at 18 No. S K Muslim Road Kamarhati Near Sogra Medical Five Point Crossing, Kolkata, West Bengal, India – 700058.
Medigift Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Medigift Pharmaceuticals is compliant as of 26 July 2026. The company is actively filing with the Registrar of Companies.